Active Surveillance of Pregnancies Ending in Stillbirths in Arkansas

对阿肯色州以死产告终的妊娠进行主动监测

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Each year 3.2 million stillbirths occur globally. In the U.S. and other developed countries, stillbirths is a largely under-studied perinatal outcome despite being one of the most common adverse pregnancy outcomes, accounting for one-half of all perinatal deaths. In 2006, the most recent data available for the U.S., stillbirths occurred in 6.05 of every 1,000 live births plus fetal deaths, much higher than many high-income countries and the U.S. Healthy People 2020 Objective of 5.6 (per 1,000 live births + fetal deaths) for fetal mortality rates. Stillbirths are poorly ascertained in the United States and most developed and developing countries. The most recent national data available on stillbirth prevalence is from 2006 which underscores the insufficient infrastructure currently in place for ascertainment and monitoring of this important perinatal outcome. In 2005, the Centers for Disease Control and Prevention (CDC) explored the feasibility of expanding two existing state birth defects surveillance programs, and the success of these pilot studies demonstrated that expanding current methods of existing birth defects registries for stillbirth surveillance is a viable and cot-effective method for surveillance of stillbirths. CDC announced a new initiative, which is a supplement to the Birth Defects Study to Evaluate Pregnancy exposureS (BD-STEPS) study, to pilot the expansion of existing state birth defects registries in the Centers for Birth Defects Prevention and Research to include surveillance of stillbirths without birth defects and to conduct pilot studies to investigate modifiable risk factors for stillbirths. The Arkansas Center's long-term goal is to prevent or significantly reduce the occurrence of birth defects and adverse pregnancy outcomes. We propose to implement a population-based, active surveillance system of stillbirths without birth defects in Arkansas; identify novel modifiable pregnancy exposures that decrease the occurrence of stillbirths by participating in this pilot study as a supplement to BD-STEPS; and discover gene- environment interactions that lead to stillbirths by supporting high-throughput genomic and epigenomic analyses of biological samples collected from NBDPS and BD-STEPS participants using institutional and extramural funds that augment CDC funding. Through our studies, we will maintain a leading role in establishing health strategies to prevent birth defects and stillbirths.
 描述(申请人提供):全球每年发生320万例死产。在美国和其他发达国家,死产在很大程度上是一种研究不足的围产期结局,尽管它是最常见的不良妊娠结局之一,占所有围产期死亡的一半。2006年,美国可获得的最新数据显示,死产发生在 每1000名活产婴儿中有6.05人死亡,远远高于许多高收入国家和美国2020年健康人口目标5.6(每1000名活产婴儿+胎儿死亡)的胎儿死亡率。在美国以及大多数发达国家和发展中国家,死产的确认率很低。关于死产发生率的最新国家数据是2006年的,这凸显了目前在确定和监测这一重要的围产期结局方面基础设施不足。2005年,美国疾病控制和预防中心(CDC)探索了扩大现有两个州出生缺陷监测项目的可行性,这些试点研究的成功表明,扩大现有出生缺陷登记的现有方法用于死产监测是一种可行且成本效益高的死产监测方法。CDC宣布了一项新的倡议,这是对出生缺陷研究的补充,以评估怀孕暴露(BD-STEPS)研究,试点扩大出生缺陷预防和研究中心现有的州出生缺陷登记,以包括对没有出生缺陷的死产的监测,并进行试点研究,以调查死产的可改变的风险因素。阿肯色州中心的 长期目标是预防或显著减少出生缺陷和不良妊娠结局的发生。我们建议在阿肯色州实施一个以人口为基础的、积极的无出生缺陷死产监测系统;通过参与这项初步研究作为对以下方面的补充,确定新的可改变的妊娠暴露,以减少死产的发生 BD-STEPS;并通过利用增加CDC资金的机构和外部资金,支持从NBDPS和BD-STEPS参与者那里收集的生物样本的高通量基因组和表观基因组分析,发现导致死产的基因-环境相互作用。通过我们的研究,我们将在制定预防出生缺陷和死产的卫生战略方面发挥主导作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHARLOTTE A HOBBS其他文献

CHARLOTTE A HOBBS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHARLOTTE A HOBBS', 18)}}的其他基金

Data Coordinating and Operations Center (DCOC) for the IDeA States Pediatric Clinical Trials Network
IDeA 州儿科临床试验网络数据协调和运营中心 (DCOC)
  • 批准号:
    9263498
  • 财政年份:
    2016
  • 资助金额:
    $ 25万
  • 项目类别:
Birth Defects Study To Evaluate Pregnancy exposureS
评估妊娠暴露的出生缺陷研究
  • 批准号:
    8911697
  • 财政年份:
    2013
  • 资助金额:
    $ 25万
  • 项目类别:
Birth Defects Study To Evaluate Pregnancy exposureS
评估妊娠暴露的出生缺陷研究
  • 批准号:
    8722863
  • 财政年份:
    2013
  • 资助金额:
    $ 25万
  • 项目类别:
Birth Defects Study To Evaluate Pregnancy exposureS
评估妊娠暴露的出生缺陷研究
  • 批准号:
    8610677
  • 财政年份:
    2013
  • 资助金额:
    $ 25万
  • 项目类别:
Genetic and Metabolic Determinants of Congenital Heart Defect Risk
先天性心脏病风险的遗传和代谢决定因素
  • 批准号:
    7863983
  • 财政年份:
    2009
  • 资助金额:
    $ 25万
  • 项目类别:
Centers for Birth Defects Research and Prevention (CBDRPs)
出生缺陷研究和预防中心 (CBDRP)
  • 批准号:
    7742237
  • 财政年份:
    2008
  • 资助金额:
    $ 25万
  • 项目类别:
Centers for Birth Defects Research and Prevention (CBDRPs)
出生缺陷研究和预防中心 (CBDRP)
  • 批准号:
    8194835
  • 财政年份:
    2008
  • 资助金额:
    $ 25万
  • 项目类别:
Centers for Birth Defects Research and Prevention (CBDRPs)
出生缺陷研究和预防中心 (CBDRP)
  • 批准号:
    8398909
  • 财政年份:
    2008
  • 资助金额:
    $ 25万
  • 项目类别:
Centers for Birth Defects Research and Prevention (CBDRPs)
出生缺陷研究和预防中心 (CBDRP)
  • 批准号:
    7996634
  • 财政年份:
    2008
  • 资助金额:
    $ 25万
  • 项目类别:
Centers for Birth Defects Research and Prevention (CBDRPs)
出生缺陷研究和预防中心 (CBDRP)
  • 批准号:
    7671902
  • 财政年份:
    2008
  • 资助金额:
    $ 25万
  • 项目类别:

相似海外基金

Nuclear RNA surveillance and its connection to splicing quality control
核 RNA 监测及其与剪接质量控制的联系
  • 批准号:
    DP240102611
  • 财政年份:
    2024
  • 资助金额:
    $ 25万
  • 项目类别:
    Discovery Projects
Multiomics for the diagnostic and surveillance of infectious diseases
用于传染病诊断和监测的多组学
  • 批准号:
    502560
  • 财政年份:
    2024
  • 资助金额:
    $ 25万
  • 项目类别:
Active one health surveillance in LMICs to monitor and predict Antimicrobial Resistance Using Metagenomics (ALARUM)
在中低收入国家中开展主动单一健康监测,利用宏基因组学 (ALARUM) 监测和预测抗菌药物耐药性
  • 批准号:
    MR/Y034287/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25万
  • 项目类别:
    Research Grant
FightAMR: Novel global One Health surveillance approach to fight AMR using Artificial Intelligence and big data mining
FightAMR:利用人工智能和大数据挖掘对抗 AMR 的新型全球统一健康监测方法
  • 批准号:
    MR/Y034422/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25万
  • 项目类别:
    Research Grant
SENSORBEES: Sensorbees are ENhanced Self-ORganizing Bio-hybrids for Ecological and Environmental Surveillance
传感器蜂:传感器蜂是用于生态和环境监测的增强型自组织生物杂交体
  • 批准号:
    10109956
  • 财政年份:
    2024
  • 资助金额:
    $ 25万
  • 项目类别:
    EU-Funded
Secure Management of Internet of Things Data for Critical Surveillance
关键监控物联网数据的安全管理
  • 批准号:
    LP230100276
  • 财政年份:
    2024
  • 资助金额:
    $ 25万
  • 项目类别:
    Linkage Projects
TEXAS: Towards next-generation AMR surveillance: Assessment of novel technologies with high-throughput and multiplexing potential
德克萨斯州:迈向下一代 AMR 监测:评估具有高通量和多重潜力的新技术
  • 批准号:
    MR/Z000017/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25万
  • 项目类别:
    Research Grant
MEtaGenome-informed Antimicrobial resistance Surveillance: Harnessing long-read sequencing for an analytical, indicator and risk assessment framework
基于 MEtaGenome 的抗菌药物耐药性监测:利用长读长测序构建分析、指标和风险评估框架
  • 批准号:
    MR/Y034457/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25万
  • 项目类别:
    Research Grant
Optimising disease surveillance to support decision-making
优化疾病监测以支持决策
  • 批准号:
    DP240102286
  • 财政年份:
    2024
  • 资助金额:
    $ 25万
  • 项目类别:
    Discovery Projects
Beyond Big Brother: New Narratives for Understanding Surveillance
超越老大哥:理解监控的新叙述
  • 批准号:
    DE240101246
  • 财政年份:
    2024
  • 资助金额:
    $ 25万
  • 项目类别:
    Discovery Early Career Researcher Award
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了